Jamaican Scientist’s Marijuana-Based Anti-Cancer Drug Has Been Approved by the FDA

Truth Troubles

(THIS ARTICLE IS COURTESY OF GLOBAL VOICES)

This Jamaican Scientist’s Marijuana-Based Anti-Cancer Drug Has Been Approved by the FDA

Sativa; photo by Dank Depot, CC BY-NC 2.0.

The U.S. Food and Drug Administration (FDA) recently granted orphan drug approvalfor Chrysoeriol, a cannabis-based drug used to treat acute myeloid leukaemia, which was developed by Jamaican scientist Dr. Henry Lowe.

Dr. Lowe founded Medicanja Ltd — described as “Jamaica’s first medical cannabis company” — in 2013. Its distinguished board of directors includes two former prime ministers and a former governor general.

The US Orphan Drug Act gives special status to a drug or biological product to treat a rare disease or condition upon the request of a sponsor. Under the act, Dr Lowe will qualify for some development incentives, including tax credits for some clinical testing.

After presenting his research findings at the 2017 Global Health Catalyst Summit

View original post 1,047 more words

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s